Coforix closes €3M pre-seed round for its open generative AI platform

A promising advance for healthcare: Coforix (founded as HealthSage AI), less than a year after its inception, today announces a €3M pre-seed investment to enhance and scale its open generative AI platform fully dedicated to healthcare. This platform will offer a trusted and transparent foundation for the development and adoption of AI applications for healthcare, including Coforix’s own LLM.

Investment Highlights

The over-subscribed €3M pre-seed round is led by Peak, with co-investments from Healthy.Capital, Rubio Impact Ventures and serial health tech entrepreneurs Jaap Maljers and Jeroen Tas. This funding enables Coforix to grow the team, commercialize its offerings, and accelerate customer deployments with real impact for healthcare professionals and patients. Together, these steps build towards Coforix’s ultimate goal: providing a comprehensive platform that will offer AI tools to enhance the efficiency and effectiveness of healthcare delivery for healthcare providers, organizations and patients.

Origins and Vision

Coforix was founded in 2023 by Marcel Alberti and Harm-Jan Wessels. Together, they bring decades of healthcare and medical software experience in building successful scale-ups and through medtech corporates.

Generative AI has massive potential to impact healthcare delivery. Next to reducing the administrative burden for healthcare professionals (up to 40% of their time), AI will provide clinical decision support, address staffing shortages through virtual interactions, make patients better informed health consumers, and enable value-based care through better insights into vast amounts of clinical data. To deliver on this promise, Coforix is building its open generative AI platform, allowing healthcare providers and health IT vendors to use generative AI in a safe and compliant way.

Johan van Mil, co-founder & managing partner at Peak says: “Given the opportunity to improve diagnostic accuracy, patient care, and operational efficiency, we see a huge opportunity for AI in the health space. Given the track-record of the founders in building and scaling companies in medtech, we see Coforix as the leading player to revolutionize the medical industry.”

The Coforix LLM

In healthcare, vast amounts of vital information are trapped in unstructured clinical notes and data. Coforix’s Large Language Model (LLM) transforms unstructured medical notes into a structured FHIR output: the global standard for electronic healthcare information exchange.

For example, once transformed by the LLM, the structured information can be used to automatically create a patient overview, offering healthcare professionals a concise summary of a patient’s health issues without the need to sift through unstructured notes. It can also simplify administrative duties, such as the creation of discharge letters. Additionally, the Coforix LLM can support clinical decision-making, helping healthcare professionals to deliver the best care by automatically leveraging structured data. It also has the capability to transform complex clinical notes into language that is easily understandable for patients, making them better informed in their own care journeys.

All in all, the LLM tackles one of the most pressing challenges in healthcare: transforming dense, hard-to-navigate unstructured clinical notes into clear, actionable information. This will lighten the load for healthcare professionals, allowing them to concentrate more on providing patient care. The Coforix LLM can be integrated into existing healthcare information systems and be used by health IT vendors to build new applications.

About the investors

Peak is a venture capital fund based in Berlin, Amsterdam, and Stockholm, financed and run by experienced entrepreneurs. For the past 15 years, Peak has fiercely backed founders across Europe, with a laser focus on early-stage SaaS, marketplace, and platform models, helping them with their Go-To-Market.

Healthy.Capital is a leading early-stage investment fund based in the Netherlands focused on healthcare startups with a vision of transforming healthcare. As an impact-driven investor, Healthy.Capital increases accessibility and affordability of healthcare for everyone.

Rubio Impact Ventures is a leading impact venture fund based in the Netherlands. Rubio invests in world-changing entrepreneurs who unite powerful positive impact with a scalable commercial business, offering its investments a winning blend of capital, expertise, and network access.

Jaap Maljers and Jeroen Tas are serial health tech entrepreneurs and angel investors who co-invested in the round.